Browse the latest research summaries in the field of regenerative medicine & stem cells for spinal cord injury patients and caregivers.
Showing 2,301-2,310 of 2,317 results
Frontiers in Bioengineering and Biotechnology, 2022 • November 1, 2022
This mini-review summarizes fabrication and modification techniques for PLLA-based biomaterial scaffolds in neural tissue engineering. It presents recent applications in peripheral nerve and spinal co...
KEY FINDING: Electrospun PLLA scaffolds, especially those with aligned nanofibers, promote nerve cell proliferation, guide neurite extension, and modulate macrophage polarization towards anti-inflammation.
Bioeng Transl Med, 2024 • May 1, 2024
This study investigates the efficacy of photobiomodulation (PBM) in promoting neuroregeneration and functional recovery after spinal cord injury (SCI) using both implantable (iPBM) and transcutaneous ...
KEY FINDING: Optimal neuroprotection in vitro was achieved with PBM between 4 and 22 mW/cm2, with 11 mW/cm2 for 1 min per day (0.66 J/cm2) increasing cell viability by 45% and neurite outgrowth by 25%.
Front. Cell Dev. Biol., 2023 • May 9, 2023
This article examines the history of lampreys in neurobiology since the 1830s, emphasizing their role in spinal cord regeneration research after 1959. The large nerve cells and basal evolutionary posi...
KEY FINDING: Functional recovery in lampreys after spinal cord injury can occur through imperfect axonal regrowth and compensatory plasticity.
BMC Developmental Biology, 2007 • May 24, 2007
This study investigates the regeneration of neural crest derivatives, specifically melanophores and spinal ganglia, in the Xenopus tadpole tail after amputation. The findings indicate that melanophore...
KEY FINDING: Cells do not emigrate from the spinal cord during tail regeneration, indicating that a new neural crest is not induced as in embryonic development.
Stem Cell Research & Therapy, 2020 • April 23, 2020
This study investigates the role of hepatocyte growth factor (HGF) in mesenchymal stem cell (MSC)-induced recovery in spinal cord injured (SCI) rats. The researchers found that MSCs promote neurologic...
KEY FINDING: Conditioned medium from bone marrow-derived MSCs (BMSCs) promotes neural stem cell differentiation into neurons and neurite outgrowth by inhibiting the BMP/Smad signaling pathway.
Stem Cell Reports, 2020 • July 14, 2020
The study investigates cell transplantation for SCI in chronic settings, using skin-derived precursors differentiated into Schwann cells (SKP-SCs) in rats 8 weeks post-injury. SKP-SCs survived transpl...
KEY FINDING: SKP-SCs survived long-term at the site of chronic SCI, integrated into the host spinal cord, and mitigated astroglial scar formation.
Cell Adhesion & Migration, 2012 • November 1, 2012
Two recent studies show that activating integrin signaling in dorsal root ganglion (DRG) neurons renders them able to overcome inhibitory signals, and could possibly lead to new strategies to improve ...
KEY FINDING: Addition of CSPGs to dorsal root ganglion (DRG) cultures resulted in a reduction of activated integrins and growth inhibition. By adding manganese to the cultures, both FAK phosphorylation and growth response was restored, indicating that integrin activation is sufficient to override the inhibitory effects of CSPGs.
Brain and Spine, 2025 • January 23, 2025
This study comprehensively examines the temporospatial dynamics of vascular injury and regeneration following experimental spinal cord injury (SCI) in mice, focusing on changes in vascular density, pe...
KEY FINDING: Vascular injury is most severe initially at the epicenter and spreads to surrounding spinal cord regions, with a delayed vascular loss observed in peritraumatic regions.
Neural Regeneration Research, 2023 • March 31, 2023
This study demonstrated the neuroprotective role of Rheb in promoting axon regeneration and increasing RGC survival after ONC. Overexpression of caRheb in RGCs activated the mTORC1 pathway, leading to...
KEY FINDING: Overexpression of constitutively active Rheb promoted survival of retinal ganglion cells in the acute (14 days) and chronic (21 and 42 days) stages of injury.
Prenatal Diagnosis, 2021 • January 1, 2021
This systematic review and meta-analysis evaluated the safety and efficacy of stem cell transplantation in animal models of MMC, finding beneficial effects on animal survival, defect coverage, and spi...
KEY FINDING: Intra-amniotic injection of allogeneic amniotic fluid mesenchymal stem cells (AF-MSCs) in the fetal rat model did not compromise fetal survival.